1st clinical trials for COVID-19 vaccine in S. Korea to kick off
SEOUL, June 4 (Yonhap) -- A Seoul-based international vaccine research institute said Thursday that it will start clinical trials of a vaccine for the novel coronavirus in South Korea.
The first and second phase clinical trials of the COVID-19 vaccine candidate, dubbed INO-4800, are expected to kick off here by the end of this month, according to the International Vaccine Institute (IVI).
The clinical trials for the COVID-19 vaccine will be the country's first.
The trials will be conducted in cooperation with Seoul National University (SNU) Hospital by using DNA vaccine candidate developed by U.S. pharmaceutical firm Inovio Pharmaceuticals Inc, the IVI said.
The trials are funded by the Coalition for Epidemic Preparedness Innovations (CEPI) and supported by the Korea Center for Disease Control and Prevention (KCDC), it said.
"South Korea is one of the first countries in the world set to test a COVID-19 vaccine (after the U.S., China, UK, and Germany), and we are happy to collaborate with South Korean partners to accelerate clinical development of a COVID-19 vaccine through our partnership with INOVIO and CEPI." said Dr. Jerome Kim, director general of IVI, in a press release.
Currently, three sets of research by research organizations are under way, and other local biotech firms have also joined the race to develop a COVID-19 vaccine.
However, their research is at a relatively early stage, lagging far behind foreign rivals, according to experts.
The IVI said speedy regulatory approval was made possible after the Korean Ministry of Food and Drug Safety adopted a fast-track approval process for clinical trials of COVID-19 vaccines.
In the midst of the COVID-19 pandemic, trials will be conducted just two months after a similar clinical study began in the United States in early April.
"Social distancing is making life challenging in all different aspects of our society, including business, education, culture, sports, and international exchange, and we have reached a point where social distancing is not sustainable any longer," said Oh Myoung-don of SNU Hospital, who will lead the clinical trials.
khj@yna.co.kr
(END)
-
(URGENT) Russian, Chinese warplanes enter S. Korea's air defense zone without notice: JCS
-
Premier League Golden Boot winner Son Heung-min receives hero's welcome home
-
Multiple Russian, Chinese warplanes enter KADIZ without notice: JCS
-
(LEAD) At least 8 injured in S-Oil refinery explosion in Ulsan: firefighters
-
Hyundai Motor to invest US$5 bln in U.S. for robotics, autonomous driving development
-
(5th LD) Yoon, Biden agree to expand joint military exercises to cope with N.K. threats
-
(LEAD) Multiple Russian, Chinese warplanes enter KADIZ without notice: JCS
-
(LEAD) At least 8 injured in S-Oil refinery explosion in Ulsan: firefighters
-
(LEAD) Biden set to arrive in S. Korea for first summit with Yoon
-
With historic Golden Boot, Son Heung-min cements case as greatest S. Korean footballer ever
-
Premier League Golden Boot winner Son Heung-min receives hero's welcome home
-
Multiple Russian, Chinese warplanes enter KADIZ without notice: JCS
-
(2nd LD) N. Korea tests nuclear detonation device: presidential office
-
(5th LD)N. Korea fires 3 ballistic missiles, including 1 suspected ICBM: S. Korean military
-
(LEAD) N. Korea tests nuclear detonation device: presidential office